SS 23 - Emerging Pathways and Targeted Therapies

Presentations

• 03:00pm - 03:10pm ET

  Gut-Derived Short-Chain Fatty Acids Orchestrate Tumor Metabolic and T-cell Immune Reprogramming to Potentiate Radiotherapy Efficacy in Head and Neck Cancer

  Speaker: Chee Kin Then, MD - Shuang Ho Hospital, Taipei Medical University, New Taipei City
• 03:10pm - 03:20pm ET

  Overcoming Myeloid-Driven Resistance of High-Grade Gliomas to CAR T Cell Therapy: Mechanistic Determinants and Therapeutic Targeting

  Speaker: Sharareh Gholamin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte
• 03:20pm - 03:30pm ET

  Pelvic Radiation-Induced Tumors in Mice Recapitulate the Histologic and Anatomic Spectrum of Human Secondary Malignancies

  Speaker: John Kincaid, MS, MPhil - Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston
• 03:30pm - 03:40pm ET

  CDCP1-Directed ⁸⁹Zr/¹⁷⁷Lu Radiotheranostics for Radioresistant Non-Small Cell Lung Cancer

  Speaker: Jie Liu, PhD - Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
• 03:40pm - 03:50pm ET

  Lineage Tracing to Characterize Response to Radiation and Immunotherapy in Breast Cancer

  Speaker: Abigail Marshall, PhD, BS - Geisel School of Medicine at Dartmouth, Lebanon
• 03:50pm - 04:00pm ET

  CRISPR Screening Identifies PCCB as a Mitochondrial Driver of Radioresistance via Stabilizing Mitochondrial Homeostasis

  Speaker: Lingyi Kong, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan